apbiocode产品代理
apbiocode产品代理
该公司开发、制造和商业化的多路诊断测试产品。Applied BioCode, Inc.将“数字条形码”与免疫化学和分子探针相结合，创造了一种新的、生物启发的条形码磁珠(BMB)技术。这种微型的BMB，直径只有人类头发那么大，用免疫化学或分子探针做了标记，使得数字条形码可以很容易地扫描并准确地识别出数量非常多(4096个条形码)的生物目标，没有歧义。
Applied BioCode, Inc.的产品专注于价值45亿美元的分子诊断传染病市场，用于检测胃肠道感染、呼吸道感染和其他高价值疾病的病原体。该公司目前已获得FDA批准的BioCode®MDx-3000系统具有17个胃肠道病原体面板(GPP)和17个呼吸道病原体面板(RPP)。胃肠道病原体小组(GPP)也获得了CE-Mark，用于符合CE-Mark法规的欧洲国家。Applied BioCode, Inc.还获得了美国FDA的紧急使用授权(EUA)，用于其BioCode®SARS-CoV-2检测*。
Assays - Clinical Diagnostics
IVD Kits
Analyte Specific Reagents
Instruments
Assays - Life Science
BMB & Accessories
Assay Services
Applied BioCode, Inc. has offices in the US and Taiwan. The company currently has over 60 employees focused on research and development, instrument design, manufacturing, and US commercialization.
The company develops, manufactures, and commercializes multiplex diagnostic testing products. Applied BioCode, Inc. has combined "digital barcodes" with immunochemistry and molecular probes to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The microscale BMB, with a diameter of human hair, is tagged with immunochemistry or molecular probes, allowing the digital barcode to be easily scanned and accurately identified for a very high number (4,096 barcodes) of biological targets with no ambiguity.
Applied BioCode, Inc. products focus on the $4.5 billion molecular diagnostic infectious disease segment of the market with assays that detect pathogens for gastrointestinal infections, respiratory infections and other high value diseases. The company has currently received FDA Clearance for the BioCode® MDx-3000 system with a 17-plex Gastrointestinal Pathogen Panel (GPP) and a 17-plex Respiratory Pathogen Panel (RPP). The Gastrointestinal Pathogen Panel (GPP) has also obtained the CE-Mark for use in European countries conforming to CE-Mark regulations. Applied BioCode, Inc. has also been granted an Emergency Use Authorization (EUA) from the U.S. FDA for its BioCode® SARS-CoV-2 Assay*.
